These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16581149)

  • 1. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging.
    Van den Heuvel F; Fugazzi J; Seppi E; Forman JD
    Radiother Oncol; 2006 Apr; 79(1):94-100. PubMed ID: 16581149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-line setup corrections only marginally reduce the number of on-line corrections for prostate radiotherapy using implanted gold markers.
    van der Vight LP; van Lin EN; Spitters-Post I; Visser AG; Louwe RJ
    Radiother Oncol; 2009 Mar; 90(3):359-66. PubMed ID: 18930328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of systematic setup errors in prostate radiation therapy: how many images to perform?
    Ludbrook JJ; Greer PB; Blood P; D'yachkova Y; Coldman A; Beckham WA; Runkel J; Olivotto IA
    Med Dosim; 2005; 30(2):76-84. PubMed ID: 15922173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.
    Kotte AN; Hofman P; Lagendijk JJ; van Vulpen M; van der Heide UA
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):419-25. PubMed ID: 17513059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer.
    van der Heide UA; Kotte AN; Dehnad H; Hofman P; Lagenijk JJ; van Vulpen M
    Radiother Oncol; 2007 Jan; 82(1):38-45. PubMed ID: 17141903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment.
    Mutanga TF; de Boer HC; Rajan V; Dirkx ML; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):400-7. PubMed ID: 22019244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients.
    Pehlivan B; Pichenot C; Castaing M; Auperin A; Lefkopoulos D; Arriagada R; Bourhis J
    Acta Oncol; 2009; 48(3):440-5. PubMed ID: 19031160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers.
    de Boer HC; van Os MJ; Jansen PP; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):969-83. PubMed ID: 15752876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India.
    Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB
    J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients.
    van Haaren PM; Bel A; Hofman P; van Vulpen M; Kotte AN; van der Heide UA
    Radiother Oncol; 2009 Mar; 90(3):291-8. PubMed ID: 19195732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods.
    Beltran C; Herman MG; Davis BJ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):289-95. PubMed ID: 17919837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Set-up errors due to endorectal balloon positioning in intensity modulated radiation therapy for prostate cancer.
    Wang CW; Chong FC; Lai MK; Pu YS; Wu JK; Cheng JC
    Radiother Oncol; 2007 Aug; 84(2):177-84. PubMed ID: 17706309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers.
    Aubry JF; Beaulieu L; Girouard LM; Aubin S; Tremblay D; Laverdière J; Vigneault E
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):30-9. PubMed ID: 15337537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT.
    McDermott LN; Wendling M; Sonke JJ; van Herk M; Mijnheer BJ
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1568-77. PubMed ID: 17394951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data.
    Curtis W; Khan M; Magnelli A; Stephans K; Tendulkar R; Xia P
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):700-6. PubMed ID: 22795802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cone beam CT evaluation of patient set-up accuracy as a QA tool.
    Nielsen M; Bertelsen A; Westberg J; Jensen HR; Brink C
    Acta Oncol; 2009; 48(2):271-6. PubMed ID: 18759138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
    Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric consequences of intrafraction prostate motion.
    Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.